Literature DB >> 28800668

[Epidemiology, Risk Factors and Risk Stratification of Venous Thromboembolism in Pregnancy and the Puerperium].

Panagiotis Tsikouras1, Georg-Friedrich von Tempelhoff2, Werner Rath3.   

Abstract

Venous thromboembolism (VTE) remains a leading cause of direct maternal deaths in the developed countries. The incidence of VTE has increased significantly during the past two decades. The absolute risk of VTE is estimated 0.6-2.2 per 1000 deliveries. Compared with age-matched non-pregnant women, the daily risk of VTE is increased 7- to 10-fold for antepartum VTE, but it is 15- to 35-fold for postpartum VTE. The incidence of pulmonary embolism (PE) during the first 6 weeks postpartum is nearly 15-fold higher compared to the incidence in pregnancy, and remains significantly increased up to 12 weeks postpartum. The case fatality rate of PE ranges from 2.2 to 6.6%.The basis of VTE prevention is careful assessment of individual risk factors of VTE and proper risk stratification.It is necessary to differentiate preexisting maternal from transient pregnancy-specific risk factors. Women with previous VTE or hereditary high-risk thrombophilias or with the antiphospholipid syndrome have the highest risk for VTE in pregnancy and the puerperium.Other most important pregnancy-specific risk factors in the antenatal period are severe ovarian hyperstimulation syndrome, hyperemesis, major surgery, severe comorbidities (e.g., systemic lupus erythematodes), hospitalization in women with a body mass index > 25 kg/m2, and inflammatory bowel diseases.Heart diseases, stillbirth, systemic infections, severe postpartum hemorrhage in combination with blood product replacement and/or surgery and emergency caesarean section are predominant risk factors in the postpartum period.Recommendations for risk stratification vary among current international guidelines. According to the SOGC (Society of Obstetricians and Gynaecologists of Canada) 2014, pharmacologic VTE prophylaxis is recommended if the estimated absolute risk of one or multiple risk factors is greater than 1%.The ACCP (American College of Chest Physicians) Guideline 2012 presents specific recommendations only for post-caesarean risk-factor-based prophylaxis.The recent RCOG (Royal College of Obstetricians and Gynaecologists) Guideline No. 37a 2015 recommends risk stratification for VTE prophylaxis on the basis of a special risk scoring system weighting individual risk factors between one point (low risk) to a maximum of 4 points (very high risk).A check list of important risk factors and a management plan for thromboprophylaxis based on current guidelines should be readily available in each obstetric unit. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2017        PMID: 28800668     DOI: 10.1055/s-0043-107618

Source DB:  PubMed          Journal:  Z Geburtshilfe Neonatol        ISSN: 0948-2393            Impact factor:   0.685


  4 in total

1.  A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran.

Authors:  Majid Mokhtari; Khadijeh Nasri; Fatemeh Tara; Elahe Zarean; Sedigheh Hantoushzadeh; Mehrnaz Radmehr; Maryam Kashanian
Journal:  J Family Reprod Health       Date:  2019-03

2.  Impact of Pregnancy-Related Venous Thromboembolism on Quality of Patients' Lives.

Authors:  Naser Al-Husban; Leena N Alnsour; Zaid El-Adwan; Nada A Saleh; Mazen El-Zibdeh
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

3.  The Prevalence of Ectopic Gestation: A Five-Year Study of 1273 Cases.

Authors:  Yan-Yan Fan; Yi-Nan Liu; Xin-Tong Mao; Yan Fu
Journal:  Int J Gen Med       Date:  2021-12-14

4.  Identification of molecular markers for pre-thrombotic state: validation in the rabbits with tibia fracture or lung cancer.

Authors:  Yan Qi; Xin Hu; Jing Chen; Qian Wu; Xiaobin Ying; Yan Shi
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.